BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million
September 05, 2019 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address...
Neuronascent Appoints New Board Member
April 12, 2017 06:30 ET
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - April 12, 2017) - Neuronascent, Inc., a neuro-pharmaceutical company developing proprietary therapeutics for Alzheimer's disease, Parkinson's disease, and psychiatric...
Neuronascent, Inc. Announces Issuance of US Patent Covering Second-Generation Neurorestorative Therapeutic Candidate
January 29, 2014 07:00 ET
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Jan 29, 2014) - Neuronascent, Inc. announced today the issuance of the United States patent covering a new compound family that includes Neuronascent's lead...
Neuronascent, Inc. Announces Issuance of Canadian Patent Covering Its Lead Alzheimer's Disease Candidate
June 25, 2013 12:39 ET
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Jun 25, 2013) - Neuronascent, Inc. announced today the issuance of a Canadian patent covering its compound families that include Neuronascent's Alzheimer's...